Sponsors (56)
The bill strengthens congressional oversight and restricts use of U.S. forces without a new authorization—boosting accountability and limiting open‑ended military commitments—but at the cost of reduced executive flexibility, potential delays in responding to emergent threats, friction between branches, and possible impacts on counternarcotics effectiveness and spending.
Congress (and therefore taxpayers and the public) gains clearer authority over whether U.S. forces may be used in hostilities: the bill reaffirms that only Congress can authorize war, increasing legislative oversight and constitutional checks on presidential use of force.
Service members and the public are less likely to be drawn into new, open‑ended foreign hostilities: the bill reduces the risk that U.S. forces will be used in new hostilities without a new congressional AUMF, which can lower deployments and combat exposure.
Border communities and local authorities benefit from a shift toward civilian law‑enforcement approaches to drug trafficking and a congressional signal to fund interdiction (intelligence, detection technology, personnel) at ports of entry, potentially strengthening non‑military drug interdiction.
Military personnel and the public may face slower responses to emergent maritime, transnational, or terrorist threats because the bill limits the President's flexibility to use force without new congressional authorization.
Federal employees, military planners, and allies could face increased political and operational friction between Congress and the White House, producing uncertainty and delays for missions and decisionmaking during crises.
Border communities and local governments could see reduced effectiveness of international counternarcotics and interdiction efforts if timely congressional authorization is not obtained, undermining operations against drug‑trafficking organizations.
Based on analysis of 2 sections of legislative text.
Introduced September 19, 2025 by Jason Crow · Last progress September 19, 2025
Requires the President to stop using U.S. Armed Forces in hostilities against organizations designated as foreign terrorist organizations or specially designated global terrorists on or after February 20, 2025, the states where those groups operate, and non-state organizations engaged in drug trafficking—unless Congress declares war or passes a specific authorization for the use of military force. It also finds that two U.S. strikes in September 2025 met the War Powers Resolution definition of hostilities and that Congress has not received sufficient information about those strikes. The measure preserves the U.S. right to defend against an armed attack or imminent armed attack and allows use of forces supporting civil authorities for authorized counternarcotics operations, while clarifying that drug trafficking alone is not an armed attack that justifies military force without congressional authorization.